Management of Benign Prostatic Hyperplasia: Defining the Role of Tamsulosin

By Katherine F. Croom   Antona J. Wagstaff  

Disease Management & Health Outcomes, Vol. 12, Iss. 5, 2004-01 ,pp. : 337-350

Adis International

Access to resources Recommend Favorite

The appropriateness of treatment of benign prostatic hyperplasia: a comparison of Dutch and multinational criteria

By McDonnell J.   Stoevelaar H.J.   Ruud Bosch J.L.H.   Kahan J.P.   Members of the Dutch Panels on the Appropriate of BPH   Members of the European Panels on the Appropriate Treatment of BPH  

Health Policy, Vol. 57, Iss. 1, 2001-07 ,pp. : 45-56

Elsevier

Access to resources Recommend Favorite

Disease Management Programs to Promote Early Diagnosis and Treatment of Benign Prostatic Hyperplasia

By Speakman M.J.  

Disease Management & Health Outcomes, Vol. 11, Iss. 1, 2003-01 ,pp. : 7-10

Adis International

Access to resources Recommend Favorite

Tau as a Molecular Marker of Development, Aging and Neurodegenerative Disorders

By  

Current Aging Science, Vol. 1, Iss. 1, 2008-03 ,pp. : 56-61

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Mechanisms in Aging and Current Strategies to Counteract Sarcopenia

By  

Current Aging Science, Vol. 3, Iss. 2, 2010-07 ,pp. : 90-101

Bentham Science Publishers

Access to resources Recommend Favorite